Skip to main content
Clinical Trials/ISRCTN12777415
ISRCTN12777415
Active, not recruiting
未知

Biomarkers & accelerate magnetic resonance imaging for dementia diagnosis

niversity of London0 sites170 target enrollmentFebruary 21, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Dementia
Sponsor
niversity of London
Enrollment
170
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 21, 2024
End Date
July 1, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity of London

Eligibility Criteria

Inclusion Criteria

  • 1\. An individual with ability to engage in the decision to participate in the research study and provide informed consent
  • 2\. Aged 18 years old and above
  • Main study: Patients attending the CDC at NHNN and at Darent Valley Hospital who are due to have a standard\-of\-care MRI of the brain as part of their routine investigation.
  • Sub\-study 1: Participants in other REC approved studies, who are scheduled for a planned MRI brain scan
  • Sub\-study 2: Healthy controls recruited through spouses/partners of patients, individuals who are included on the DRC Research Register and Join Dementia Research and patients attending the CDC at NHNN and at Darent Valley Hospital
  • Sub\-study 3: Participants recruited to the main study who are happy to be contacted about follow\-up study procedures

Exclusion Criteria

  • 1\. Unable to tolerate a routine MRI scan plus a 7\-minute fast\-MRI scan
  • 2\. Unable to tolerate draw blood by venepuncture

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
on-Invasive Magnetic Resonance Imaging Biomarkers to Evaluate Histology Proven Kidney Fibrosis in Chronic Kidney DiseaseChronic Kidney DiseaseRenal and Urogenital - Kidney disease
ACTRN12622000855729Professor Martin Ugander68
Completed
Not Applicable
se of Advanced Magnetic Resonance Imaging (MRI)- a neuroimaging modality- for predicting functional outcome in severe traumatic brain injuryHealth Condition 1: S060- ConcussionHealth Condition 2: S064- Epidural hemorrhageHealth Condition 3: S063- Focal traumatic brain injuryHealth Condition 4: S068- Other specified intracranial injuriesHealth Condition 5: S061- Traumatic cerebral edemaHealth Condition 6: S066- Traumatic subarachnoid hemorrhageHealth Condition 7: S065- Traumatic subdural hemorrhageHealth Condition 8: S069- Unspecified intracranial injury
CTRI/2019/04/018800IMHANS intramural funding32
Recruiting
Not Applicable
Magnetic Resonance Imaging (MRI) Biomarker Study: an observational study to assess differential changes that occur in the brains of participants with various neurodegenerative diseases using MRI technology.Alzheimer's disease [AD]Frontotemporal dementia [FTD]Parkinson's disease [PD]motor neuron disease [ALS]progressive supranuclear palsy [PSP]corticobasal degeneration [CBD]Dementia with Lewy BodiesNeurological - Neurodegenerative diseasesNeurological - Alzheimer's diseaseNeurological - Parkinson's diseaseNeurological - Dementias
ACTRN12618002032235niversity of Queensland400
Recruiting
Not Applicable
Advanced MRI techniques and biomarkers to substitute gadolinium enhanced MRI for the detection of disease activity in multiple sclerosis.Multiple Sclerosis10007951
NL-OMON53657Amsterdam UMC75
Not yet recruiting
Not Applicable
Magnetic resonance imaging for phenotyping and accurate Monitoring of Interstitial Lung Disease: the M-ILD studyInterstitiele longziekten (Interstitial Lung Disease, ILD)Interstitial lung diseases (ILD)lung diseases
NL-OMON51937Erasmus MC, Universitair Medisch Centrum Rotterdam60